Page 9 - Read Online

Cancer Drug Resistance
CONTENTS

Topic: Epigenetic Basis of Cancer Drug Resistance

Editorial

1 Epigenetic basis of cancer drug resistance
Moammir H. Aziz, Aamir Ahmad
Cancer Drug Resist 2020;3:113-116 http://dx.doi.org/10.20517/cdr.2020.06

Original Article

2 Daunorubicin can eliminate iPS-derived cancer stem cells via ICAD/CAD-independent DNA
fragmentation
Akimasa Seno, Akifumi Mizutani, Kazuki Aizawa, Ryoma Onoue, Junko Masuda, Naotaka Ochi, Saki
Taniguchi, Tatsuyuki Sota, Yuki Hiramoto, Taisuke Michiue, Neha Nair, Masaharu Seno
Cancer Drug Resist 2019;2:335-350 http://dx.doi.org/10.20517/cdr.2019.01

Review

3 Epigenetics, a key player of immunotherapy resistance
Paul Peixoto, Elodie Renaude, Michaël Boyer-Guittaut, Eric Hervouet
Cancer Drug Resist 2018;1:219-229 http://dx.doi.org/10.20517/cdr.2018.17

4 Alkylating anticancer agents and their relations to microRNAs
Bernhard Biersack
Cancer Drug Resist 2019;2:1-17 http://dx.doi.org/10.20517/cdr.2019.09

5 The epigenome in pediatric acute lymphoblastic leukemia: drug resistance and therapeutic
opportunities
Lauren K. Meyer, Michelle L. Hermiston
Cancer Drug Resist 2019;2:313-325 http://dx.doi.org/10.20517/cdr.2019.11

6 Resistance to cis- and carboplatin initiated by epigenetic changes in ovarian cancer patients
Heidi Schwarzenbach, Peter B. Gahan
Cancer Drug Resist 2019;2:271-296 http://dx.doi.org/10.20517/cdr.2019.010

7 Overcome cancer drug resistance by targeting epigenetic modifications of centrosome
Zan-Hui Jia, Xing-Gang Wang, Hong Zhang
Cancer Drug Resist 2019;2:210-224 http://dx.doi.org/10.20517/cdr.2018.010

8 Role of cellular reprogramming and epigenetic dysregulation in acquired chemoresistance in
breast cancer
Logeswari Ponnusamy, Prathap Kumar S. Mahalingaiah, Yu-Wei Chang, Kamaleshwar P. Singh
Cancer Drug Resist 2019;2:297-312 http://dx.doi.org/10.20517/cdr.2018.11